Wojciech Zgliczynski
Overview
Explore the profile of Wojciech Zgliczynski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
606
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bornikowska K, Kubik P, Zgliczynski W
Prz Menopauzalny
. 2025 Jan;
23(4):200-206.
PMID: 39811389
The increase of the incidence of autoimmune diseases and, at the same time, a significant surge in the number of regenerative/anti-aging medicine treatments carried out, raises the need to systematise...
2.
Wozniak B, Leszczynska D, Szatko A, Nowak K, Samsel R, Siejka A, et al.
Front Endocrinol (Lausanne)
. 2024 Dec;
15:1499836.
PMID: 39640880
In adrenal steroidogenesis, 17-hydroxyprogesterone (17-OHP) is a substrate for 21-hydroxylase, one of the crucial enzymes of the cortisol and aldosterone biosynthesis pathway. Thus, measurement serum 17-OHP concentration is used when...
3.
Tanska K, Glinicki P, Rebizant B, Dudek P, Zgliczynski W, Gietka-Czernel M
Biomedicines
. 2024 Nov;
12(11).
PMID: 39595192
: Thyroid autoimmunity (TAI) affects about 15% of women of reproductive age and can negatively affect pregnancy outcomes. One possible mechanism for pregnancy complications can be attributed to a disturbed...
4.
Iwanowska M, Kochman M, Szatko A, Zgliczynski W, Glinicki P
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39519190
Primary hyperparathyroidism (PHPT) is a common endocrinopathy, predominantly caused by a single parathyroid adenoma that is responsible for the excessive secretion of parathyroid hormone (PTH)-the hallmark of disease. Excess of...
5.
Blazowska O, Strozna K, Dancewicz H, Zygmunciak P, Zgliczynski W, Mrozikiewicz-Rakowska B
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518461
Immunotherapy is one of the greatest advancements in oncological patient care. The broader the treatment application, the more common the adverse events associated with the therapy. Immune checkpoint inhibitors (ICI)...
6.
Sawicka-Gutaj N, Glinicki P, Nijakowski K, Brominska B, Ostrowska M, Szatko A, et al.
Ther Adv Endocrinol Metab
. 2024 Oct;
15:20420188241277414.
PMID: 39464531
Background: Saliva could be an attractive alternative to blood for assessing thyroid hormonal function. Objectives: Our goal was to determine if the levels of thyroid hormones in saliva can accurately...
7.
Ostrowska-Czyzewska A, Zgliczynski W, Bednarek-Papierska L, Mrozikiewicz-Rakowska B
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407860
Glucocorticoids (GS) are widely used in multiple medical indications due to their anti-inflammatory, immunosuppressive, and antiproliferative effects. Despite their effectiveness in treating respiratory, skin, joint, renal, and neoplastic diseases, they...
8.
Szatko A, Badura B, Leszczynska D, Wozniak B, Zgliczynski W, Glinicki P
Pol Arch Intern Med
. 2024 Sep;
135(1).
PMID: 39315738
No abstract available.
9.
Kleibert M, Mrozikiewicz-Rakowska B, Korycka K, Plachta I, Bak P, Balut D, et al.
Wiad Lek
. 2024 Sep;
77(7):1318-1324.
PMID: 39241128
Objective: Aim: Type 2 diabetes mellitus (T2DM) is a widespread disease that leads to many complications if not adequately controlled. The pandemic and its limitations on healthcare access impaired the...
10.
Wydra A, Wydra J, Gatarek J, Zgliczynski W, Czajka-Oraniec I
Endokrynol Pol
. 2024 Jun;
75(3):32-329.
PMID: 38923901
Not required in Clinical Vignettes.